Universidade Federal de Goiás. Hospital das Clínicas. Goiânia, GO, Brasil.
Universidade Federal de Ouro Preto. Departamento de Estatística. Ouro Preto, MG, Brasil.
Rev Saude Publica. 2021 Oct 29;55:68. doi: 10.11606/s1518-8787.2021055003122. eCollection 2021.
To analyze the evolution of syphilis during pregnancy notification regarding clinical classification, diagnosis and treatment in the state of Goiás, Brazil, between 2007 and 2017.
This is a time-series study, analyzing data provided by the Health Secretariat of the state of Goiás. The variables related to the diagnosis and treatment of pregnant women and their partners were analyzed, and their evolution trend during the years. Descriptive statistics and percentage calculation were used. Cochran-Armitage test with a significance level α = 0.05 was used to determine increase and decrease trends.
During the period, 7,774 cases were notified. The highest percentage of notifications occurred in the second trimester of pregnancy (39.8%) and corresponded to primary syphilis (34.1%). The most frequent treatment prescribed was benzathine benzylpenicillin with a dosage of 7.2 million (43.8%). Between 2007 and 2017, there was an increasing trend in the notification percentage of latent (14.1% to 30.7%), secondary (5.2% to 19%), and tertiary syphilis (4.4% to 11.4%). The treatment with benzathine benzylpenicillin with a dosage of 7.2 million also increased (19.3% to 59.6%). The percentages of primary syphilis decreased (43.4% to 22.1%), as well as other treatments' percentages.
Latent syphilis notification of pregnant women and treatment with penicillin at the dosage of 7,200,000 IU increased. Notification forms' data completeness also increased for the variables clinical classification and treatment, suggesting improvements in the notification process.
分析巴西戈亚斯州 2007 年至 2017 年期间梅毒妊娠通知的临床分类、诊断和治疗演变情况。
这是一项时间序列研究,分析了来自戈亚斯州卫生秘书处的数据。分析了与孕妇及其伴侣诊断和治疗相关的变量,并分析了这些变量在这几年的变化趋势。采用描述性统计和百分比计算。采用 Cochran-Armitage 检验(α=0.05)确定增加和减少趋势。
在此期间,共报告了 7774 例病例。通知的百分比在妊娠中期(39.8%)最高,主要为一期梅毒(34.1%)。最常开的处方是剂量为 720 万单位的苄星青霉素(43.8%)。2007 年至 2017 年间,潜伏梅毒(14.1%至 30.7%)、二期梅毒(5.2%至 19%)和三期梅毒(4.4%至 11.4%)的通知百分比呈上升趋势。剂量为 720 万单位的苄星青霉素治疗也有所增加(19.3%至 59.6%)。一期梅毒的通知百分比下降(43.4%至 22.1%),其他治疗的百分比也有所下降。
妊娠梅毒的潜伏梅毒通知和青霉素治疗(720 万 IU)有所增加。通知表格中关于临床分类和治疗的变量的数据完整性也有所提高,表明通知流程有所改进。